All In MedTech

Device Trial Radar · NCT02758548

Determination of Accuracy in Measurement of Total Immunoglobulin E Using a Test Device in Atopic Subjects

A Multicenter Clinical Evaluation Study to Determine the External Site Accuracy of Total Immunoglobulin E Measurement Using a Novel Point of Care Test Device Compared to a Reference Method in Atopic Subjects

Last checked: Nov 19, 2026Latest source record: Nov 15, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

193

Actual

Start

Mar 2016

Primary completion

May 2016

Study completion May 2016

Sponsor

Lead sponsor
Novartis PharmaceuticalsNot on our public-company list
Sponsor type
Industry
First posted
May 2, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 6 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the accuracy of the Novel point of care test (POCT) total IgE assay in atopic patients. 120 patients with atopic conditions and approximately 40 healthy subjects will be enrolled. Fingerstick capillary blood samples will be collected and tested in the POCT device. Venous samples will be collected and sent to a reference laboratory for measurement of serum total IgE using the reference immunoassay method.

Conditions

  • Atopic Asthma

Interventions

  • Blood sampleProcedure

    Fingerprick and venous

  • POCT deviceDevice

    Investigational device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Total IgE concentrationTime frame: Day 0 or Day 1 (Visit 2: Blood sampling)

Locations

12 sites in 5 countries. Site status is shown where the registry gives one.

  • Novartis Investigative Site

    Hamburg, Germany

  • Novartis Investigative Site

    Lübeck, Germany

  • Novartis Investigative Site

    Padova, PD, Italy

9 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.